CADENCE PHARMA (CADX)
Quote
Price
$2.97
Price change for today in $
0.02
Price change for today in %
0.68
Open Price
$2.96
Previous Close
$2.95
Daily Range
$2.93 - $3.05
52-Week Range
$2.72 - $10.00
Volume
194,040
Brokerage Analyst Recommendations
10 Brokerage Firms Covering CADX
Strong Buy
6
Buy
0
Hold
3
Sell
1
Strong Sell
0
Average Broker Recommendation (ABR):1.9
Description
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III products in development, including IV APAP, for the treatment of acute pain and fever, and Omigard for the prevention of catheter-related infections. The Company is committed to the fevelopment and commercialization of pharmaceuticals to meet the needs of hospitalized patients and their caregivers.
12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO, CA 92130, USA Phone: 8584361400 Fax: 858-436-1401 Web: http://www.cadencepharm.com Email: r@cadencepharm.com
Industry: MED-DRUGS
Sector: Medical
Fiscal Year End: December
Last Reported Quarter: 03/31/12
Next EPS Date: 08/08/12
Capital Structure Solvency and Cash Flow No comments yet. Be the first
Governance Social Responsibility and Employee Relations No comments yet. Be the first
Acquisitions Divestitures and Joint Ventures No comments yet. Be the first
Recent and Upcoming Events May 21, 2012 08:20
Biotech Industry Booming in 2012
May 11, 2012 17:00
Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The JMP Securities 11th Annual Research Conference In San Francisco On May 15, 2012
May 09, 2012 15:05
Shares of Cadence Pharmaceuticals Fall Below Previous 52-Week Low
May 09, 2012 09:25
Cadence Pharmaceuticals Q1 net loss decreases
May 07, 2012 15:08
Shares of Cadence Pharmaceuticals Fall to a New 52-Week Low
May 04, 2012 20:56
Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice
May 04, 2012 15:05
Recent 52-Week Low Surpassed in Shares of Cadence Pharmaceuticals (CADX)
May 04, 2012 11:15
Investors look to Lighten Up on Shares of Cadence Pharmaceuticals, Shares Down 12.0% (CADX)
May 04, 2012 11:14
Investors look to Lighten Up on Shares of Cadence Pharmaceuticals, Shares Down 12.0% (CADX)
May 03, 2012 20:56
Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice
May 03, 2012 16:00
Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
May 02, 2012 16:00
Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8, 2012
Apr 25, 2012 20:52
Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice
Apr 24, 2012 21:32
Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice
Apr 24, 2012 20:52
Cadence Pharmaceuticals, Inc. (CADX) Corporate Event Announcement Notice
Created by: WikiMigrationBot .
Last Modification: Thursday 03 of June, 2010 06:29:17 CDT by WikiMigrationBot .